Vaccine effectiveness against COVID-related hospitalization was 38% in the 2 months after receipt of one dose and 34% at 2 to 4 months.
Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows